We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.04B
AUM Growth
+$73M
(+1.2%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
1,047
New
173
Increased
233
Reduced
390
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$50M |
| 2 |
Merck
MRK
|
+$46.7M |
| 3 |
Cognizant
CTSH
|
+$37.2M |
| 4 |
Las Vegas Sands
LVS
|
+$25.6M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$51.6M |
| 2 |
Comcast
CMCSA
|
+$48.7M |
| 3 |
Intel
INTC
|
+$38.4M |
| 4 |
Amazon
AMZN
|
+$38.4M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$36.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.81% |
| 2 | Industrials | 13.63% |
| 3 | Financials | 13.56% |
| 4 | Healthcare | 12.66% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNC
776
DELISTED
Synacor, Inc.
SYNC
| $152K | ﹤0.01% |
+59,541
| New | +$142K |
|
|
ENZ
777
DELISTED
Enzo Biochem, Inc.
ENZ
| $149K | ﹤0.01% |
28,388
+12,788
| +82% | +$55.3K |
|
778
Alpha and Omega Semiconductor
AOSL
$923M
| $147K | ﹤0.01% |
15,904
-26,350
| -62% | -$209K |
|
|
NCIT
779
DELISTED
NCI, Inc.
NCIT
| $143K | ﹤0.01% |
16,149
| – | – |
|
780
Codexis
CDXS
$135M
| $142K | ﹤0.01% |
97,563
| – | – |
|
781
Digi International
DGII
$2.52B
| $136K | ﹤0.01% |
14,400
-7,800
| -35% | -$71.3K |
|
|
ARC
782
DELISTED
ARC Document Solutions, Inc.
ARC
| $132K | ﹤0.01% |
22,500
-15,900
| -41% | -$101K |
|
|
FES
783
DELISTED
Forbes Energy Services Ltd
FES
| $131K | ﹤0.01% |
+28,630
| New | +$119K |
|
|
PRSS
784
DELISTED
CafePress Inc.
PRSS
| $129K | ﹤0.01% |
+24,984
| New | +$140K |
|
|
RNWK
785
DELISTED
RealNetworks Inc
RNWK
| $129K | ﹤0.01% |
16,864
| – | – |
|
786
Innodata
INOD
$1.83B
| $127K | ﹤0.01% |
39,309
+8,537
| +28% | +$25.9K |
|
787
Sypris Solutions
SYPR
$43.7M
| $127K | ﹤0.01% |
+22,699
| New | +$93.3K |
|
|
EGIO
788
DELISTED
Edgio, Inc. Common Stock
EGIO
| $127K | ﹤0.01% |
1,036
-2,196
| -68% | -$208K |
|
|
GSOL
789
DELISTED
Global Sources Ltd
GSOL
| $124K | ﹤0.01% |
14,970
-2,675
| -15% | -$22.5K |
|
|
MSO
790
DELISTED
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
| $124K | ﹤0.01% |
+26,300
| New | +$114K |
|
791
1-800-Flowers.com
FLWS
$245M
| $119K | ﹤0.01% |
20,600
-7,300
| -26% | -$41K |
|
|
FGH
792
DELISTED
FG Group Holdings Inc.
FGH
| $119K | ﹤0.01% |
28,540
-13,200
| -32% | -$57.9K |
|
|
PCMI
793
DELISTED
PCM, Inc
PCMI
| $118K | ﹤0.01% |
11,028
-12,800
| -54% | -$128K |
|
794
AXT Inc
AXTI
$3.09B
| $117K | ﹤0.01% |
54,716
+19,355
| +55% | +$42.3K |
|
|
CBB
795
DELISTED
Cincinnati Bell Inc.
CBB
| $115K | ﹤0.01% |
+5,854
| New | +$107K |
|
|
ARQL
796
DELISTED
Arqule Inc
ARQL
| $114K | ﹤0.01% |
73,625
+42,004
| +133% | +$65.7K |
|
|
EDMC
797
DELISTED
EDUCATION MGMT CORP NEW COM STK (PA)
EDMC
| $109K | ﹤0.01% |
64,249
+6,200
| +11% | +$16.7K |
|
|
PCTI
798
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $106K | ﹤0.01% |
13,041
+1,900
| +17% | +$15K |
|
|
ALXA
799
DELISTED
Alexza Pharmaceuticals Inc
ALXA
| $106K | ﹤0.01% |
23,100
+10,600
| +85% | +$45.8K |
|
|
ZAGG
800
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $104K | ﹤0.01% |
+19,100
| New | +$88.1K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2014 Portfolio in Review
As of Q2 2014, Jacobs Levy Equity Management held 1,047 positions worth $6.04B, up 1.2% from $5.97B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2014 filing shows 173 new, 233 increased, 390 reduced and 225 closed positions. Its largest new stake was Merck: 856,750 shares worth $47.3M. The largest sale was DIRECTV COM STK (DE), an estimated $51.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
- Jacobs Levy Equity Management's largest Q2 2014 buy was Merck: 856,750 shares worth $47.3M.
- Jacobs Levy Equity Management added most to Pfizer in Q2 2014, an estimated $50M increase.
- Jacobs Levy Equity Management's biggest Q2 2014 reduction was Comcast, cutting an estimated $48.7M.
- Jacobs Levy Equity Management fully exited DIRECTV COM STK (DE) in Q2 2014, selling an estimated $51.6M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.04B portfolio in Q2 2014.
- Jacobs Levy Equity Management opened 173 new positions and closed 225 in Q2 2014.
- Jacobs Levy Equity Management's portfolio value rose 1.2% quarter-over-quarter to $6.04B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2014, filed 14 Aug 2014.